Last updated 2026-08-21
- Raised Seed round led by Y Combinator, 2021
Total raised
—
Stage
—
Founded
2021
Headcount
—
HQ
New York City, United States
Sector
Healthcare
About
Output Biosciences is an AI-based platform for drug discovery and development, utilizing computational biology and AI technology to discover and predict target molecules for the prevention of chronic diseases. The company is building Large Biological Models that can generate breakthrough medicines and transform the way diseases are diagnosed, treated, and prevented.
Funding history · 1 round · — total
2021
Seed
Undisclosed
★ Y Combinator
Q&A
- What is Output Biosciences' primary focus?
- Output Biosciences focuses on pioneering Biologically-Aware Generative AI to understand complex biological systems for drug discovery and development.
- When was Output Biosciences founded?
- Output Biosciences was founded in 2021.
- Where is Output Biosciences headquartered?
- Output Biosciences is headquartered in New York City, United States.
- Which investors participated in Output Biosciences' Seed funding round?
- Output Biosciences received Seed funding in 2021 from Y Combinator.
- What technology does Output Biosciences utilize for drug discovery?
- Output Biosciences utilizes computational biology and AI technology, specifically building Large Biological Models, to discover and predict target molecules for chronic diseases.
- Who are the co-founders of Output Biosciences?
- The co-founders of Output Biosciences are Mirella Mashiach and Adi Mashiach, both appointed in 2021.
Team · 2
Mirella Mashiach
Founder · Co-Founder
Adi Mashiach
Founder · Co-Founder
Sectors & technology
Primary sector
Healthcare
Technologies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | outputbio.com |
|---|
Identifiers & details
| Founded | 2021 |
|---|